Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Janssen Submits sNDA for Xarelto to Prevent VTE in Acute Medically Ill Patients

americanpharmaceuticalreviewDecember 17, 2018

Tag: Janssen , sNDA , sNDA , VTE

PharmaSources Customer Service